Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT07454499
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Digital Endocrine therapy Symptom Monitoring and Education Intervention — BEHAVIORAL
    Patients will receive text messages with links to symptom monitoring surveys and educational materials on possible symptoms from endocrine therapy.

Study Details

The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symptoms from hormone therapy and to stay on their hormone therapy for the recommended period of time.

Key Dates

Start date
Apr 1, 2026
Status verified
Mar 2026
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: ARM A Intervention
    Patients assigned to symptom monitoring web-based intervention.
  • No Intervention: ARM B Usual care
    Participants will be provided with an educational handout describing endocrine therapy.

Primary Outcome Measure

System Usability Scale (SUS) [ Time Frame: Once during study exit survey at 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Abramson Cancer Center at the University of PennsylvaniaPhiladelphiaPennsylvania19104
Kimberley Lee, MD

Find similar trials in Philadelphia, PA

Related Studies